- $11.75bn
- $8.13bn
- $3.70bn
- 96
- 49
- 40
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,159 | 2,667 | 2,986 | 3,395 | 3,696 |
Cost of Revenue | |||||
Gross Profit | 2,066 | 2,557 | 2,857 | 3,209 | 3,463 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,757 | 2,930 | 2,400 | 2,815 | 3,075 |
Operating Profit | 402 | -264 | 586 | 579 | 621 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 487 | -232 | 570 | 529 | 834 |
Provision for Income Taxes | |||||
Net Income After Taxes | 447 | -296 | 949 | 341 | 598 |
Net Income Before Extraordinary Items | |||||
Net Income | 447 | -296 | 949 | 341 | 598 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 447 | -296 | 949 | 341 | 598 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.14 | -1.16 | 4.42 | 1.58 | 2.74 |